Ionis Pharmaceuticals, Inc. (IONS)
79.11
+0.14
(+0.18%)
USD |
NASDAQ |
Dec 31, 16:00
79.00
-0.11
(-0.14%)
After-Hours: 20:00
Ionis Pharmaceuticals Research and Development Expense (TTM): 879.75M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 12.56B |
| Merck & Co., Inc. | 14.26B |
| Pfizer Inc. | 10.13B |
| Cogent Biosciences, Inc. | 251.67M |
| Perspective Therapeutics, Inc. | 61.22M |